Related Experiment Video
Updated: Jun 14, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Exploring the patient perspective in pulmonary hypertension
H James Ford1, Colleen Brunetti2, Pisana Ferrari3
1University of North Carolina at Chapel Hill, Pulmonary Hypertension Program, Division of Pulmonary and Critical Care Medicine, Chapel Hill, NC, USA.
Pulmonary hypertension (PH) treatments have improved, but patient wellbeing and mental health challenges persist globally. This study addresses care access, patient support, and integrating patient-reported outcomes for better PH management.
Area of Science:
- Cardiology
- Public Health
- Patient Advocacy
Background:
- Pulmonary hypertension (PH) was recognized globally in 1973, leading to decades of therapeutic advancements.
- Despite improved treatments, PH significantly impacts patients' wellbeing and mental health.
- There's a critical need to understand global patient challenges in care access and support.
Purpose of the Study:
- To enhance understanding of global patient challenges in pulmonary hypertension (PH) care access and support.
- To analyze the benefits of incorporating patient-reported outcomes (PROs) into PH diagnosis and treatment.
- To explore the impact of global threats on PH patients and propose mitigation strategies.
Main Methods:
- Global surveys of patient and healthcare provider experiences and challenges regarding care access.
- Analysis of the current state and potential enhancements for PH patient associations worldwide.
- Review of patient-reported outcome measures for assessing health-related quality of life in PH.
Main Results:
- Identified significant global disparities in PH care access and patient support.
- Highlighted the importance of patient associations in providing multidimensional support.
- Presented relevant PRO measures and suggested their integration into clinical practice and research.
Conclusions:
- Addressing global challenges in PH care access and patient support is crucial.
- Integrating PROs can improve PH diagnosis, treatment, and patient-centered care.
- Proactive planning is needed to mitigate the impact of global threats on PH patients.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

